
Prof. Dorothy Mbori-Ngacha reflects on the early years of HIV/AIDS in Kenya, marked by stigma and a lack of effective treatment, and how social isolation worsened the epidemic.
She discusses the introduction of Nevirapine in 2003, which reduced mother-to-child transmission by 50%, offering hope to Kenyan mothers.
Prof. Mbori-Ngacha also explores how international support, particularly from PEPFAR, revolutionized Kenya’s HIV response, improving pediatric care, education, and community-based interventions.
She addresses ongoing barriers to HIV care for key populations and outlines Kenya’s commitment to the UNAIDS 95-95-95 targets and “Triple Elimination” goals in the fight for an AIDS-free generation by 2030.
You are free to republish this article online or in print, provided that you attribute the author and Willow Health Media, and link back to the original article.
Note: Images are not included unless otherwise specified.
Copy and paste the HTML below into your site:
Remember to include the attribution and a backlink to Willow Health Media.
Loading article details…
Sign in to your account